Larson Financial Group’s Jade Biosciences JBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding JBIO
Larson Financial Group's JBIO Position: Q3 2026 in Review
Larson Financial Group reduced its Jade Biosciences (JBIO) stake by 0.96% in Q3 2026, selling an estimated $20 and leaving 103 shares worth $1.45K. The position accounts for ﹤0.01% of the portfolio, ranked #3316.
Larson Financial Group first reported a position in JBIO in Q4 2025 and has held it in 4 quarters since. The position peaked at $2.31K in Q2 2026. 162 funds tracked by Wall St. Rank hold JBIO as of Q3 2026.
- Larson Financial Group held 103 shares of Jade Biosciences worth $1.45K as of Q3 2026.
- Larson Financial Group sold 1 Jade Biosciences share in Q3 2026, an estimated $20.
- Jade Biosciences made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #3316 holding.
- Larson Financial Group first reported a position in Jade Biosciences in Q4 2025 and has held it in 4 quarters since.
- Larson Financial Group's Jade Biosciences position peaked at $2.31K in Q2 2026.
- 162 funds tracked by Wall St. Rank held Jade Biosciences as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.